Article
Nephrotic syndrome genomic discovery in the Mass General Brigham Biobank identifies monoallelic MEFV variants as a risk factor for focal segmental glomerulosclerosis.
Kidney international - 1 Apr 2026
Wongboonsin Janewit, Gibson Kristen M, Ke Juntao, Sentell Zachary T, Arcila-Galvis Juliana E, Koyama Satoshi, Greenberg Anya, Reynolds Kaylia M, Montini Giovanni, Magistroni Riccardo, Mitrotti Adele, Gesualdo Loreto, Pezzuto Alessandro, Peruzzi Licia, Caliskan Yasar, Onuchic-Whitford Ana C, Bunlungsup Srichan, McNulty Michelle, Gbadegesin Rasheed, Saleem Moin A, Pollak Martin R, Hildebrandt Friedhelm, Natarajan Pradeep, Lee Dongwon, Nigwekar Sagar U, Sayer John A, Sanna-Cherchi Simone, Sampson Matthew G
Abstract excerpt
INTRODUCTION: Health system-based biobanks with genetic data provide a unique opportunity for nephrotic syndrome (NS) genomic discovery. This is predicated on finding cases in the electronic health record. METHODS: We tested three strategies to identify focal segmental glomerulosclerosis (FSGS) or minimal change disease (MCD) cases in the 130,000 members of Mass General Brigham Biobank (MGBB). We analyzed a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
